Method for increasing the bioavailability of glycopyrrolate

Details Method for increasing the bioavailability of glycopyrrolate Method for increasing the bioavailability of glycopyrrolate

2009-12-28

2010-10-19

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07816396

ABSTRACT:
The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.

REFERENCES:
patent: 3532794 (1970-10-01), Alphin
patent: 4600708 (1986-07-01), Reuter et al.
patent: 6063808 (2000-05-01), Fabiano et al.
patent: 6204285 (2001-03-01), Fabiano et al.
patent: 6407128 (2002-06-01), Scaife et al.
patent: 6433003 (2002-08-01), Bobrove et al.
patent: 6455557 (2002-09-01), Pellegrini et al.
patent: 7091236 (2006-08-01), Roberts et al.
patent: 7638552 (2009-12-01), Roberts et al.
patent: 2 019 180 (1994-09-01), None
patent: WO 01/08681 (2001-02-01), None
patent: WO 2006/078998 (2006-07-01), None
patent: WO 2008/131340 (2008-10-01), None
Charman et al.,J. Pharm. Sci., 86(3): 269-282 (Mar. 1997).
Kirk et al.,Am. Fam. Physician, 51(5): 1175-1182 (Apr. 1995).
Mier et al.,Arch. Pediatr. Adolesc. Med., 154: 1214-1218 (Dec. 2000).
Toothaker et al.,Ann. Rev. Pharmacol. Toxicol., 20: 173-199 (1980).
Welling,Clinical Pharmacokinetics, 9: 404-434 (1984).
Winstanley et al.,Br. J. Clin. Pharmac., 28: 621-628 (1989).
Ali-Melkkilä et al.,Acta Anaesthesiol Scand, 33, 513-517 (1989).
Ali-Melkkilä et al.,Acta Anaesthesiol Scand, 37, 633-642 (1993).
Bachrach et al.,Clinical Pediatrics, 37(8): 485-490 (Aug. 1998).
Chen, Connie,Am. J. Health-Syst Pharm, 55, 905-025 (May 1, 1998).
Evans, Allan M.,Therapeutic Drug Monitoring, 22, 131-136 (2000).
Gillen et al.,Best Pract Res Clin Gastroenterol, 15 (3), 487-495 (Jun. 2001).
Greene et al.,Clin. Pharmacokinet, 33 (4), 260-275 (Oct. 1997).
Loi et al.,Clin. Pharmacokinet, 37 (2), 91-104 (Aug. 1999).
Martinez et al.,J. Clin. Pharmacol, 42, 620-643 (2002).
Pelkonen et al.,Eur. J. Clin. Pharmacol., 57, 621-629 (2001).
Radus et al.,J. Pharm. Sci., 72(3): 221-224 (Abstract) (Mar. 1983).
Rautakorpi et al.,J. Clin. Anesth., 6, 217-220 (May/Jun. 1994).
Rautakorpi et al.,Pharmacology&Toxicology, 83, 132-134 (1998).
Singh, Brahma N.,Clin. Pharmacokinet, 37 (3), 213-255 (Sep. 1999).
Temple et al.,Annals Pharmacotherapy, 33, 1203-1210 (Nov. 1999).
Van Leerdam et al.,Best Prac Res Clin Gastroenterol, 15 (3), 463-475 (2001).
Walter-Sack et al.,Clin. Pharmacokinet, 31 (1), 47-64 (Jul. 1996).
Kaye et al.,Gut, 9: 590-596 (1968).

Affiliated with

Also associated with

Rating

Method for increasing the bioavailability of glycopyrrolate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for increasing the bioavailability of glycopyrrolate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing the bioavailability of glycopyrrolate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183049